Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Agnosia 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain, Postoperative 1Opioid-Related Disorders 1Neoplasms 1Mucositis 1Goiter 1Cancer Pain 1Brain Neoplasms 1

Interventions

Morphine 11Oxycodone 8Fentanyl 6nabiximols 5Methadone 4Hydromorphone 4Acetaminophen 3Transcutaneous Electric Nerve Stimulation 2Tapentadol 2Naloxone 2Lidocaine 2Buprenorphine 2Acupuncture Therapy 2tanezumab 1resiniferatoxin 1oxycodone naloxone combination 1fulranumab 1cannabichromene 1alvimopan 1Water 1Ultracet 1Transcranial Direct Current Stimulation 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tablets 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cancer Pain × Tramadol × Clear all
NCT05311774 2025-12-03

Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain

Assiut University

Phase NA Completed
400 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡